Summary: Emerging research suggests high blood pressure and certain forms of heart failure can be influenced by metabolites produced in the gut. Scientists have uncovered a direct communication pathway linking gut bacteria, a specific group of neurons in the brain, and the heart. The bacterial metabolite indole-3 acetic acid (IAA) appears to act as a regulatory “brake” on stress-sensitive neurons in the hypothalamus, and when IAA is depleted, those neurons overactivate and contribute to heart muscle stiffening known as diastolic dysfunction.
These findings point to several promising prevention and treatment strategies—ranging from dietary adjustments and probiotics to targeted supplementation—that could help lower the risk of hypertension and heart failure by restoring healthy gut-brain-heart signaling.
Key Facts
- IAA Brake: Gut bacteria metabolize the amino acid tryptophan into indole-3 acetic acid (IAA). This small molecule travels to the brain and modulates activity of hypocretin (Hcrt) neurons.
- Brain as a Hub: Hypocretin neurons in the hypothalamus act as a central switch in the gut-brain-heart axis. Low IAA removes inhibition on these neurons, increasing sympathetic output to the heart.
- Diastolic Dysfunction: Overactivity of this circuit stiffens the heart muscle and impairs relaxation, helping to explain diastolic dysfunction and its role in heart failure with preserved ejection fraction (HFpEF).
- Human Connection: Analysis of patient samples showed lower circulating IAA in people with hypertension, with a notably stronger reduction in hypertensive women.
- Biomarker Potential: Serum IAA could serve as an early indicator of heightened cardiovascular risk and offer a target for preventive lifestyle or therapeutic interventions.
Source: MDC
Overview
Hypertension and heart failure affect millions worldwide, yet clinicians often lack a clear mechanistic explanation for why the heart becomes stiff and fails to relax in many patients. New laboratory work from the Max Delbrück Center led by Dr. Suphansa Sawamiphak identifies a gut→brain→heart signaling pathway that helps fill this gap in understanding. The research highlights how changes in gut microbial communities and their metabolites can influence central nervous system circuits that ultimately regulate cardiac structure and function.
From gut microbes to hypothalamic neurons
Using zebrafish as an experimental model, the investigators tracked how disturbances in ion homeostasis produced gut dysbiosis and reduced abundance of microbes that generate indole derivatives. Targeted metabolomics revealed a consistent drop in indole-3 acetic acid (IAA) in animals with diastolic dysfunction. Functional experiments showed that IAA directly dampens activity of hypocretin (Hcrt) neurons in the hypothalamus—cells that influence sleep, appetite, and autonomic control of the heart.
When IAA levels were low, Hcrt neurons became overactive. This led to increased sympathetic signaling to cardiac-projecting ganglia, elevated activity of the renin-angiotensin-aldosterone system, and measurable stiffening of the ventricle that impaired its ability to relax during diastole. Restoring IAA—either by supplementing the metabolite or preserving the microbiota that produce it—normalized neuronal firing, lowered sympathetic drive, and improved cardiac relaxation and hemodynamic measures.
Evidence from human samples
To assess clinical relevance, the team examined human serum metabolite profiles and found that IAA was reduced in individuals with hypertension. The reduction was particularly pronounced in hypertensive women, suggesting sex-specific vulnerability in the gut-brain-heart signaling pathway. While these human data are correlative, they align closely with the experimental results from zebrafish and strengthen the case for IAA as a biomarker and possible therapeutic target.
Clinical implications and next steps
Diastolic dysfunction is common in older adults and underlies many cases of HFpEF, which accounts for a large proportion of heart failure diagnoses. The new findings suggest multiple, nonexclusive avenues for intervention:
- Use of serum IAA levels as an early biomarker to identify people at risk of hypertension-related cardiac remodeling;
- Dietary strategies to increase tryptophan intake combined with microbiota-focused approaches that favor IAA-producing bacteria;
- Probiotic or metabolite supplementation aimed at restoring IAA signaling and thereby reducing sympathetic overdrive and hormonal activation that promote cardiac stiffening.
The authors emphasize that the body operates as an integrated system—not isolated organs—and that gut health and microbial balance have direct consequences for cardiac function. They caution that further work is needed: validation in additional animal models, mechanistic studies of IAA signaling receptors, and clinical trials to determine whether restoring IAA levels delivers measurable benefit to patients with hypertension or early diastolic dysfunction.
Frequently asked questions
Q: How does the gut influence the heart?
A: Gut bacteria convert dietary tryptophan into metabolites such as IAA. IAA reaches the brain and modulates hypothalamic hypocretin neurons. When IAA is low, these neurons become overactive and drive sympathetic nervous system output that can make the heart stiffer and raise blood pressure.
Q: Can diet improve this pathway?
A: The research suggests that diets containing tryptophan-rich foods may provide substrates for IAA production, but the presence of the right microbial partners is essential. Approaches that combine diet, probiotics, or direct supplementation to increase IAA are plausible strategies under investigation.
Q: Why might this matter more for women?
A: In the study cohort, hypertensive women showed lower serum IAA than men, indicating potential sex-specific differences in microbial metabolism, neurohormonal responses, or susceptibility to gut-derived signals. This observation warrants targeted follow-up.
Research details (summary)
The study combined gut microbiome profiling, targeted metabolomics, genetic and chemogenetic manipulations of hypothalamic neurons, in vivo calcium imaging, and live cardiovascular imaging in zebrafish. Antibiotic-induced microbiota depletion worsened cardiac remodeling under hypertensive challenge, while IAA supplementation reduced hypertrophy and diastolic failure in an aryl hydrocarbon receptor–dependent manner. Patient serum metabolomes showed conserved reductions in IAA among people with hypertension.
Editorial notes
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full by the editorial team.
- Additional context was provided by the staff to clarify implications and next steps for research and care.
About this research news
Author: Gunjan Sinha
Source: MDC
Contact: Gunjan Sinha – MDC
Image credit: Neuroscience News
Original research: Open access. Study title: “Indole-3 acetate limits dysbiosis-driven diastolic failure via Hcrt neurons” by Bhakti I. Zakarauskas-Seth et al., published in Circulation Research. DOI: 10.1161/CIRCRESAHA.125.326990
Abstract (condensed)
The study reveals a gut-brain-heart crosstalk in which gut dysbiosis reduces indole-3 acetic acid, permitting overactivation of hypothalamic hypocretin neurons and triggering sympathetic and hormonal pathways that drive diastolic remodeling. Modulating IAA signaling and hypocretin neuron activity offers a potential multisystem strategy to counter hypertensive heart disease.